Shares of Janone Inc. (NASDAQ:ALTS - Get Free Report) fell 3.5% during trading on Wednesday . The stock traded as low as $9.68 and last traded at $9.73. 173,929 shares changed hands during mid-day trading, a decline of 24% from the average session volume of 228,206 shares. The stock had previously closed at $10.08.
Janone Price Performance
The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 1.96. The business's 50-day simple moving average is $6.20 and its two-hundred day simple moving average is $5.28.
About Janone
(
Get Free Report)
ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments.
Read More
Before you consider Janone, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Janone wasn't on the list.
While Janone currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
